Compliance Statement
Effective: April 2026
Our compliance program
TheraVite Health, Inc. maintains a comprehensive compliance program designed to prevent, detect, and respond to violations of law, regulations, and TheraVite’s policies. The program is structured around the seven elements of an effective compliance program identified by the U.S. Department of Health and Human Services Office of Inspector General (OIG):
- Written standards — written policies, procedures, and a Code of Conduct that articulate the organization’s commitment to compliance
- Compliance leadership — designation of a Compliance Officer and Compliance Committee with authority to oversee compliance activities
- Training and education — regular compliance training for all employees, contractors, and agents
- Effective lines of communication — multiple channels for reporting compliance concerns, including an anonymous mechanism
- Auditing and monitoring — internal auditing and monitoring activities to detect compliance issues
- Enforcement and discipline — well-publicized disciplinary guidelines applied consistently
- Response and prevention — prompt response to detected violations, including corrective action and prevention of recurrence
Areas of compliance focus
- HIPAA Privacy and Security Rule compliance
- Federal Anti-Kickback Statute and Stark Law compliance
- False Claims Act compliance
- Medicare and Medicaid billing accuracy
- Drug Supply Chain Security Act (DSCSA) compliance
- FDA regulations applicable to specialty pharmacy operations
- State pharmacy licensure and practice standards
- USP General Chapter <797> standards for sterile compounding
- USP General Chapter <800> standards for hazardous drug handling
- OSHA and occupational safety standards
Reporting compliance concerns
Anyone — patients, providers, employees, contractors, vendors, or members of the public — may report a suspected compliance concern. Reports may be submitted to:
TheraVite Health, Inc.
Attn: Compliance Officer
Danbury, CT
Email: info@theravitehealth.com
Non-retaliation
TheraVite prohibits retaliation against any individual who, in good faith, reports a compliance concern, participates in an investigation, or refuses to engage in a practice the individual reasonably believes to be unlawful or unethical.
Cooperation with investigations
TheraVite cooperates fully with investigations by federal, state, and local regulatory and enforcement agencies, including the OIG, CMS, FDA, DEA, the Department of Justice, state attorneys general, state pharmacy boards, and accreditation bodies.